◀ Back to EPO
EDN2 — EPO
Text-mined interactions from Literome
Jelkmann et al., Ann Hematol 2004
(Neoplasms) :
Epo promotes angiogenesis and
stimulates the production of
endothelin and other vasoactive mediators
Kita et al., J Immunol 1995
:
MBP ( 10 micrograms/ml ) and
EPO ( 0.1 micrograms/ml )
induced EDN release comparable with one of the strongest agonists for eosinophils, secretory IgA ... Pretreatment of cells with dibutyryl cAMP or cytochalasin B completely abolished the
EDN release
induced by MBP and
EPO , suggesting that the effects of MBP and EPO are not due to cytotoxic lysis of the cells
Hon et al., Artif Organs 1995
(Kidney Failure, Chronic) :
Lack of a fast acting
effect of
erythropoietin on arterial blood pressure and
endothelin level ... This study was designed to explore the presence, if any, of fast acting
effects of
EPO on the arterial blood pressure and
endothelin level in vivo
Katoh et al., Life Sci 1994
:
Direct evidence for
erythropoietin induced release of
endothelin from peripheral vascular tissue
Haller et al., Kidney Int 1996
:
Erythropoietin (EPO) induces
endothelin expression in endothelial cells ( EC ) and has angiogenic effects